Reported Earnings • Feb 23
First half 2026 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in 1H 2025) First half 2026 results: AU$0.007 loss per share (in line with 1H 2025). Revenue: AU$201.2k (down 15% from 1H 2025). Net loss: AU$2.89m (loss widened 12% from 1H 2025). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Feb 21
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$4.2m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$4.2m free cash flow). Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Revenue is less than US$1m (AU$708k revenue, or US$502k). Minor Risk Market cap is less than US$100m (AU$30.4m market cap, or US$21.5m). New Risk • Dec 31
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 32% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (32% increase in shares outstanding). Revenue is less than US$1m (AU$744k revenue, or US$498k). Minor Risks Share price has been volatile over the past 3 months (16% average weekly change). Market cap is less than US$100m (AU$30.9m market cap, or US$20.7m). New Risk • Nov 02
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 25% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m (AU$744k revenue, or US$487k). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Shareholders have been diluted in the past year (25% increase in shares outstanding). Market cap is less than US$100m (AU$23.5m market cap, or US$15.4m). Board Change • Oct 15
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director & Company Secretary Grant Mooney was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Oct 14
Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million. Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 59,602,251
Price\Range: AUD 0.052
Discount Per Security: AUD 0.00312
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 46,166,980
Price\Range: AUD 0.052
Discount Per Security: AUD 0.00312
Transaction Features: Subsequent Direct Listing New Risk • Oct 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.8m free cash flow). Revenue is less than US$1m (AU$744k revenue, or US$491k). Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (AU$28.4m market cap, or US$18.7m). Ankündigung • Oct 09
Aurora Labs Limited, Annual General Meeting, Nov 17, 2025 Aurora Labs Limited, Annual General Meeting, Nov 17, 2025. Reported Earnings • Aug 29
Full year 2025 earnings released: AU$0.01 loss per share (vs AU$0.01 loss in FY 2024) Full year 2025 results: AU$0.01 loss per share (in line with FY 2024). Revenue: AU$743.8k (up 327% from FY 2024). Net loss: AU$3.75m (loss widened 34% from FY 2024). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. New Risk • Jun 24
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: AU$15.2m (US$9.89m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.5m free cash flow). Revenue is less than US$1m (AU$262k revenue, or US$171k). Market cap is less than US$10m (AU$15.2m market cap, or US$9.89m). Reported Earnings • Feb 24
First half 2025 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in 1H 2024) First half 2025 results: AU$0.007 loss per share (in line with 1H 2024). Revenue: AU$236.7k (up 59% from 1H 2024). Net loss: AU$2.59m (loss widened 52% from 1H 2024). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. New Risk • Feb 21
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.5m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.5m free cash flow). Shareholders have been substantially diluted in the past year (38% increase in shares outstanding). Revenue is less than US$1m (AU$262k revenue, or US$168k). Minor Risk Market cap is less than US$100m (AU$29.5m market cap, or US$18.9m). New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 37% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (37% increase in shares outstanding). Revenue is less than US$1m (AU$174k revenue, or US$108k). Minor Risk Market cap is less than US$100m (AU$33.8m market cap, or US$21.1m). New Risk • Nov 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (AU$174k revenue, or US$112k). Minor Risk Market cap is less than US$100m (AU$29.8m market cap, or US$19.3m). Ankündigung • Nov 06
Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million. Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 26,666,667
Price\Range: AUD 0.075
Discount Per Security: AUD 0.00375
Transaction Features: Subsequent Direct Listing Ankündigung • Sep 24
Aurora Labs Limited, Annual General Meeting, Nov 14, 2024 Aurora Labs Limited, Annual General Meeting, Nov 14, 2024. Reported Earnings • Aug 23
Full year 2024 earnings released: AU$0.01 loss per share (vs AU$0.014 loss in FY 2023) Full year 2024 results: AU$0.01 loss per share (improved from AU$0.014 loss in FY 2023). Net loss: AU$2.81m (loss narrowed 5.3% from FY 2023). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Ankündigung • May 01
Aurora Labs Limited, Annual General Meeting, May 30, 2024 Aurora Labs Limited, Annual General Meeting, May 30, 2024, at 10:00 W. Australia Standard Time. Location: 41-43 Wittenberg Drive, Canning Vale, Western Australia Canning Vale Western Australia Australia Agenda: To consider the Ratification of Placement Shares pursuant to Listing Rule 7.1; to consider the Issue of Placement Options; to consider the Issue of Placement Shares and Placement Options to Mr Grant Mooney; and to consider other matters. Ankündigung • Apr 23
Aurora Labs Limited has filed a Follow-on Equity Offering in the amount of AUD 2.04 million. Aurora Labs Limited has filed a Follow-on Equity Offering in the amount of AUD 2.04 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 65,166,667
Price\Range: AUD 0.03
Discount Per Security: AUD 0.0018
Security Features: Attached Options
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 2,833,333
Price\Range: AUD 0.03
Discount Per Security: AUD 0.0018
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing New Risk • Feb 24
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Revenue is less than US$1m (AU$220k revenue, or US$144k). Market cap is less than US$10m (AU$8.11m market cap, or US$5.32m). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Shareholders have been diluted in the past year (26% increase in shares outstanding). Ankündigung • Dec 22
Aurora Labs Limited ORDINARY FULLY PAID to Be Deleted from OTC Equity Aurora Labs Limited ORDINARY FULLY PAID (Australia) will be deleted from OTC Equity effective December 21, 2023, due to Inactive Security. Ankündigung • Nov 29
Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 0.9416 million. Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 0.9416 million.
Security Name: Ortdinary Shares
Security Type: Common Stock
Securities Offered: 35,800,000
Price\Range: AUD 0.022
Security Name: Ortdinary Shares
Security Type: Common Stock
Securities Offered: 7,000,000
Price\Range: AUD 0.022
Transaction Features: Subsequent Direct Listing New Risk • Nov 28
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$135k revenue, or US$89k). Market cap is less than US$10m (AU$6.48m market cap, or US$4.28m). Minor Risk Share price has been volatile over the past 3 months (16% average weekly change). Ankündigung • Oct 27
Aurora Labs Limited, Annual General Meeting, Nov 29, 2023 Aurora Labs Limited, Annual General Meeting, Nov 29, 2023, at 09:00 W. Australia Standard Time. Location: HLB Mann Judd, Level 4, 130 Stirling Street Perth, Western Australia Western Australia Australia Agenda: To consider the Annual Report of the Company and its controlled entities for the year ended 30 June 2023, which includes the Financial Report, the Directors' Report and the Auditor's Report; to consider remuneration report; to consider re-election of director; and to consider other matters. Reported Earnings • Aug 26
Full year 2023 earnings released: EPS: AU$0.014 (vs AU$0.018 loss in FY 2022) Full year 2023 results: EPS: AU$0.014 (up from AU$0.018 loss in FY 2022). Net loss: AU$2.96m (loss narrowed 5.9% from FY 2022). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings. Board Change • Apr 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Chairman & Company Secretary Grant Mooney was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 24
First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.011 loss in 1H 2022) First half 2023 results: AU$0.009 loss per share (improved from AU$0.011 loss in 1H 2022). Net loss: AU$1.69m (loss narrowed 4.9% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 45% per year, which means it is significantly lagging earnings. Ankündigung • Sep 15
Aurora Labs Limited, Annual General Meeting, Oct 31, 2022 Aurora Labs Limited, Annual General Meeting, Oct 31, 2022. Reported Earnings • Aug 26
Full year 2022 earnings released: AU$0.018 loss per share (vs AU$0.031 loss in FY 2021) Full year 2022 results: AU$0.018 loss per share (up from AU$0.031 loss in FY 2021). Net loss: AU$3.15m (loss narrowed 29% from FY 2021). Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 49% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Apr 15
Founder & CTO recently sold AU$307k worth of stock On the 14th of April, David Budge sold around 3m shares on-market at roughly AU$0.11 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by AU$566k. Reported Earnings • Aug 29
Full year 2021 earnings released: AU$0.03 loss per share (vs AU$0.079 loss in FY 2020) Full year 2021 results: Net loss: AU$4.42m (loss narrowed 46% from FY 2020). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 34% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Aug 03
Founder & CTO recently sold AU$224k worth of stock On the 29th of July, David Budge sold around 2m shares on-market at roughly AU$0.091 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by AU$1.0m. Is New 90 Day High Low • Feb 11
New 90-day high: AU$0.21 The company is up 144% from its price of AU$0.086 on 13 November 2020. The Australian market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Machinery industry, which is up 2.0% over the same period. 